Rong Tong
Cited by
Cited by
Photoswitchable nanoparticles for triggered tissue penetration and drug delivery
R Tong, HD Hemmati, R Langer, DS Kohane
Journal of the American Chemical Society 134 (21), 8848-8855, 2012
Reversible cell‐specific drug delivery with aptamer‐functionalized liposomes
Z Cao, R Tong, A Mishra, W Xu, GCL Wong, J Cheng, Y Lu
Angewandte Chemie International Edition 48 (35), 6494-6498, 2009
Anticancer polymeric nanomedicines
R Tong, J Cheng
Journal of Macromolecular Science, Part C: Polymer Reviews 47 (3), 345-381, 2007
Translocation of HIV TAT peptide and analogues induced by multiplexed membrane and cytoskeletal interactions
A Mishra, GH Lai, NW Schmidt, VZ Sun, AR Rodriguez, R Tong, L Tang, ...
Proceedings of the National Academy of Sciences 108 (41), 16883-16888, 2011
Near IR heptamethine cyanine dye–mediated cancer imaging
X Yang, C Shi, R Tong, W Qian, HE Zhau, R Wang, G Zhu, J Cheng, ...
Clinical cancer research 16 (10), 2833-2844, 2010
Spatiotemporal controlled delivery of nanoparticles to injured vasculature
JM Chan, L Zhang, R Tong, D Ghosh, W Gao, G Liao, KP Yuet, D Gray, ...
Proceedings of the National Academy of Sciences 107 (5), 2213-2218, 2010
Paclitaxel‐initiated, controlled polymerization of lactide for the formulation of polymeric nanoparticulate delivery vehicles
R Tong, J Cheng
Angewandte Chemie International Edition 47 (26), 4830-4834, 2008
Photoswitchable nanoparticles for in vivo cancer chemotherapy
R Tong, HH Chiang, DS Kohane
Proceedings of the National Academy of Sciences 110 (47), 19048-19053, 2013
Smart chemistry in polymeric nanomedicine
R Tong, L Tang, L Ma, C Tu, R Baumgartner, J Cheng
Chemical Society Reviews 43 (20), 6982-7012, 2014
Reprogramming the microenvironment with tumor-selective angiotensin blockers enhances cancer immunotherapy
VP Chauhan, IX Chen, R Tong, MR Ng, JD Martin, K Naxerova, MW Wu, ...
Proceedings of the National Academy of Sciences 116 (22), 10674-10680, 2019
Ring-opening polymerization-mediated controlled formulation of polylactide− drug nanoparticles
R Tong, J Cheng
Journal of the American Chemical Society 131 (13), 4744-4754, 2009
The formulation of aptamer-coated paclitaxel–polylactide nanoconjugates and their targeting to cancer cells
R Tong, L Yala, TM Fan, J Cheng
Biomaterials 31 (11), 3043-3053, 2010
Redox-responsive, core cross-linked polyester micelles
Z Zhang, L Yin, C Tu, Z Song, Y Zhang, Y Xu, R Tong, Q Zhou, J Ren, ...
ACS macro letters 2 (1), 40-44, 2013
New strategies in cancer nanomedicine
R Tong, DS Kohane
Annual review of pharmacology and toxicology 56, 41-57, 2016
Wiley Interdiscip
R Tong, DS Kohane
Rev.: Comput. Mol. Sci 7, e1305, 2017
Polylactide-cyclosporin A nanoparticles for targeted immunosuppression
J Azzi, L Tang, R Moore, R Tong, N El Haddad, T Akiyoshi, B Mfarrej, ...
The FASEB Journal 24 (10), 3927, 2010
Shedding light on nanomedicine
R Tong, DS Kohane
Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology 4 (6 …, 2012
New chemistry in functional aliphatic polyesters
R Tong
Industrial & Engineering Chemistry Research 56 (15), 4207-4219, 2017
Anticancer nanoparticulate polymer‐drug conjugate
Q Feng, R Tong
Bioengineering & translational medicine 1 (3), 277-296, 2016
Nanomedicines targeting the tumor microenvironment
R Tong, R Langer
The Cancer Journal 21 (4), 314-321, 2015
The system can't perform the operation now. Try again later.
Articles 1–20